These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22248059)

  • 1. Overexpression of Yin Yang 1 in the pathogenesis of human hematopoietic malignancies.
    Bonavida B; Huerta-Yepez S; Baritaki S; Vega M; Liu H; Chen H; Berenson J
    Crit Rev Oncog; 2011; 16(3-4):261-7. PubMed ID: 22248059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
    Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
    Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic role of Yin Yang 1.
    Zhang Q; Stovall DB; Inoue K; Sui G
    Crit Rev Oncog; 2011; 16(3-4):163-97. PubMed ID: 22248053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic potential of yin yang 1 mediated through control of imprinted genes.
    Thiaville MM; Kim J
    Crit Rev Oncog; 2011; 16(3-4):199-209. PubMed ID: 22248054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
    Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
    Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription regulator Yin-yang 1: from silence to cancer.
    Zhu W; Olson SY; Garbán H
    Crit Rev Oncog; 2011; 16(3-4):227-38. PubMed ID: 22248056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
    Kaufhold S; Garbán H; Bonavida B
    J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia.
    Beck K; Wu BJ; Ni J; Santiago FS; Malabanan KP; Li C; Wang Y; Khachigian LM; Stocker R
    Circ Res; 2010 Dec; 107(12):1490-7. PubMed ID: 21030713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yin Yang 2: the great unknown within the Yin Yang 1 regulatory network.
    Klar M
    Crit Rev Oncog; 2011; 16(3-4):239-43. PubMed ID: 22248057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM
    Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional transcription factor YY1: a therapeutic target in human cancer?
    Wang CC; Chen JJ; Yang PC
    Expert Opin Ther Targets; 2006 Apr; 10(2):253-66. PubMed ID: 16548774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1 in human cancer.
    Nicholson S; Whitehouse H; Naidoo K; Byers RJ
    Crit Rev Oncog; 2011; 16(3-4):245-60. PubMed ID: 22248058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
    Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
    Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (
    Antonio-Andrés G; Rangel-Santiago J; Tirado-Rodríguez B; Martinez-Ruiz GU; Klunder-Klunder M; Vega MI; Lopez-Martinez B; Jiménez-Hernández E; Torres Nava J; Medina-Sanson A; Huerta-Yepez S
    Leuk Lymphoma; 2018 Nov; 59(11):2628-2638. PubMed ID: 29616858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological implications of Yin Yang 1 in the hallmarks of cancer.
    Meliala ITS; Hosea R; Kasim V; Wu S
    Theranostics; 2020; 10(9):4183-4200. PubMed ID: 32226547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.
    Cho AA; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):49-61. PubMed ID: 29604936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
    Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B
    J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multilayered Regulation of the Oncogenic Protein YY1.
    Rizkallah R; Hurt MM
    Crit Rev Oncog; 2017; 22(1-2):109-129. PubMed ID: 29604940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Forgotten YY2 in Reported YY1 Expression Levels in Human Cancers.
    Kaufhold S; Aziz N; Bonavida B
    Crit Rev Oncog; 2017; 22(1-2):63-73. PubMed ID: 29604937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.